Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 87INDUSTRY 26UNKNOWN 2OTHER_GOV 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Lung 1Advanced Pancreatic Cancer 1

Interventions

Paclitaxel 5Capecitabine 5pyrotinib 4Epirubicin 4Docetaxel 4exemestane 3Vinorelbine 3Radiotherapy 3Radiation Dose Hypofractionation 3Fulvestrant 3Carboplatin 3apatinib 2Neoadjuvant Therapy 2Letrozole 2Etoposide 2Cyclophosphamide 2Albumin-Bound Paclitaxel 2toripalimab 1titanium silicide 1pirarubicin 1palbociclib 1nimotuzumab 1icaritin 1anlotinib 1Therapeutics 1Standard of Care 1Radiation 1Pemetrexed 1Nutrition Assessment 1Methods 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
UNKNOWN × Breast Neoplasms × Albumin-Bound Paclitaxel × Clear all
NCT05287308 2022-03-31

Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study

ChineseAMS

Phase NA Not yet recruiting
500 enrolled
Breast

Breast Neoplasms

NCT05291910 2022-03-23

Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast Cancer

ChineseAMS

Phase 4 Unknown
70 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡